Page 192 - Eceptor News Today

A new preprint describes the development of a new platform for evaluating the risk of SARS-CoV-2 infection in placental tissue.

A cohort study found that antibodies to the SARS-CoV-2 spike protein and neutralizing antibodies remain relatively stable 8-11 months post-infection.

Based on protein-protein interactions, the paper shows the presence of ten genes that overlap between the two illnesses, also shared by several other deadly and debilitating diseases.

In this interview, News-Medical talks to Dr. Simon Chowdhury and Laetitia Guilloux about the current state of prostate cancer, it's prevalence, treatment options and its future.

Scientists explore the link between SARS-CoV-2 infection and anti-NMDAR encephalitis.

A new study aimed to identify several potent neutralizing RBD-directed and NTD-directed mAbs that used a nanoparticle displaying the S glycoprotein to capture SARS-CoV-2-specific B cells.

A new study developed a “Made-in-Canada” solution for enabling scalable and reproducible SARS-CoV-2 serology.

A new study explores the role of new SARS-CoV-2 variants in sustaining the pandemic in South Africa.

Researchers have recently identified two nanobodies that show specific binding against a SARS-CoV-2 replication protein.

A new study develops an inhaled microfluidic microsphere with a genetically engineered membrane from the ACE2 receptor-overexpressing cells and macrophages.